These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36288891)
1. Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases. Takeda K; Kikuchi Y; Sawada YU; Kumamoto T; Watanabe J; Kuniski C; Misumi T; Endo I Anticancer Res; 2022 Nov; 42(11):5497-5505. PubMed ID: 36288891 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study. John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407 [TBL] [Abstract][Full Text] [Related]
3. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901 [TBL] [Abstract][Full Text] [Related]
4. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis]. Bao Q; Wang K; Wang HW; Jin KM; Xing BC Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993 [No Abstract] [Full Text] [Related]
5. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis. Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701 [TBL] [Abstract][Full Text] [Related]
6. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey. Kobayashi S; Beppu T; Honda G; Yamamoto M; Takahashi K; Endo I; Hasegawa K; Kotake K; Itabashi M; Hashiguchi Y; Kotera Y; Sakamoto K; Yamaguchi T; Morita S; Tabuchi K; Miyazaki M; Sugihara K J Gastrointest Surg; 2020 Jun; 24(6):1244-1260. PubMed ID: 31197683 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial. Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of risk-stratified indicators for adjuvant chemotherapy with fluorouracil and oxaliplatin after hepatectomy for colorectal cancer liver metastasis. Maruyama K; Tominaga T; Nonaka T; Moriyama M; Oyama S; Ishii M; Sawai T; Nagayasu T Int J Colorectal Dis; 2022 Jul; 37(7):1545-1552. PubMed ID: 35624174 [TBL] [Abstract][Full Text] [Related]
9. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases. Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086 [TBL] [Abstract][Full Text] [Related]
11. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy. Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K Ann Surg Oncol; 2014 Jan; 21(1):139-46. PubMed ID: 24121880 [TBL] [Abstract][Full Text] [Related]
13. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy. Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients. Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto M; Ohdan H Int J Surg; 2016 Dec; 36(Pt A):96-103. PubMed ID: 27741421 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy. van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431 [TBL] [Abstract][Full Text] [Related]
16. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection. Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267 [TBL] [Abstract][Full Text] [Related]
17. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases. Yoshimoto T; Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Ishikawa D; Teraoku H; Yoshikawa M; Higashijima J; Takasu C; Shimada M In Vivo; 2017; 31(3):419-423. PubMed ID: 28438872 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study. Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104 [TBL] [Abstract][Full Text] [Related]
19. Clinical Importance of CD200 Expression in Colorectal Liver Metastasis. Matsuo Y; Sho M; Nomi T; Hokuto D; Yoshikawa T; Kamitani N; Nakamura K; Iwasa Y Ann Surg Oncol; 2021 Sep; 28(9):5362-5372. PubMed ID: 33393050 [TBL] [Abstract][Full Text] [Related]
20. Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and Outcomes after the Resection of Colorectal Liver Metastases. Chen Q; Wu C; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J J Gastrointest Surg; 2020 Mar; 24(3):659-670. PubMed ID: 30937711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]